Low molecular weight heparins as antineoplastic agents.

Risultato della ricerca: Article

Abstract

There is an increasing interest in the potential role of low molecular weight heparins (LMWHs) in the management of cancer patients. These antithrombotic agents have generated particular excitement because they have been proved useful in both the prevention and treatment of venous thromboembolism (VTE) in patients with malignancy. Recent reports are, at the same time, highlighting a potential role of LMWHs on patient survival due to their presumed antineoplastic action. This review will discuss the most recent reports and patents on these topics.
Lingua originaleEnglish
pagine (da-a)159-161
Numero di pagine3
RivistaRecent Patents on Anti-Cancer Drug Discovery
Volume3
Stato di pubblicazionePublished - 2008

    Fingerprint

Cita questo